3 Company Earnings to Watch This Week (April 13-17)

The article previews key Q1 2026 earnings reports from JPMorgan Chase, Taiwan Semiconductor, and Netflix, with investors focused more on guidance and operating trends than on the quarterly numbers themselves. JPMorgan's full-year guidance on net interest income, expenses, and credit-card losses will be watched for signals on the economy, while TSM's $35.6 billion March-quarter revenue and AI-chip demand commentary should inform semiconductor sentiment. Netflix already raised subscription prices and is expected to provide an update on its $50.7 billion to $51.7 billion 2026 revenue outlook and a $20 billion content budget plan.

Analysis

The market is likely to misread this week as a simple earnings read-through, but the real signal is dispersion in capital intensity. JPM can tell us whether the credit cycle is turning before delinquency data does; if management tightens reserve language while spending stays disciplined, that is usually a late-cycle warning for consumer-facing cyclicals and lower-quality financials over the next 1-3 quarters. The bigger second-order effect is that any sign of consumer strain would pressure ad-supported media and discretionary subscription spend, where pricing power looks strong only until households start trading down.

TSM is the cleaner AI barometer, but the key variable is not revenue growth already reported—it is whether gross margin guidance confirms that advanced-node demand is still outrunning packaging and supply-chain bottlenecks. If margins stay firm, it supports the idea that AI capex remains concentrated among a few hyperscalers and that the next leg of upside belongs to semiconductor equipment and power-infrastructure names rather than the obvious GPU leaders. If margin guide softens, that would be the first evidence that the AI buildout is moving from scarcity pricing into digestion mode, which tends to compress multiple expansion across the entire AI basket.

NFLX is the most interesting contrarian setup because the stock is now being asked to justify both price increases and a much heavier content commitment. That combination can look great in gross additions for one or two quarters, but it raises the bar for free cash flow durability and makes the business more sensitive to churn and price-elasticity surprises in 2H26. The consensus seems to assume subscribers will absorb the hit smoothly; the risk is that content inflation forces Netflix into a treadmill where incremental revenue gets pre-committed to programming before it can re-rate the equity.

Overall, the tape likely rewards names tied to durable pricing power and punishes those that need flawless execution to defend margins. The best asymmetric opportunities are in relative-value expressions where the earnings read can shift positioning without requiring a macro thesis to play out.

Key Decisions for Investors

• Long JPM vs. KRE for the next 2-6 weeks: own the quality balance sheet and reserve discipline over regional banks if JPM commentary implies late-cycle consumer pressure; downside is limited because JPM is already the market’s preferred shelter.
• Use TSM earnings as a trigger to add semicap exposure on any confirmation of tight AI supply: long AMAT/ASML vs. short a broad AI basket over 1-3 months, because margin strength would imply bottlenecks are still monetizable upstream rather than downstream.
• If NFLX guides revenue or subscriber growth above the post-price-hike bar, sell put spreads rather than buying upside outright: the trade benefits from elevated implied volatility while limiting downside if churn appears in 2H26.
• If NFLX commentary disappoints on churn or FCF, short NFLX against WBD for a 1-2 month relative-value trade: Netflix is priced for perfect execution, while WBD has more operating leverage if the market rotates toward cheaper content assets.
• Buy NVDA on pullbacks only if TSM confirms sustained AI demand and no margin air pocket; otherwise hedge existing AI beta via short-term call spreads in NVDA into the print, since the risk/reward is skewed to a digestion phase rather than a straight-line breakout.